Laboratory assessment of multiple myeloma - ScienceDirect
MGUS: Abwarten, kontrollieren, behandeln? | Gelbe Liste
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS) | Blood Cancer Journal
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia
Multiples Myelom – Plasmozytom – Plasmazellen außer Kontrolle: Im Zentrum der Diagnostik steht das Paraprotein
Stellenwert des Hevylite®-Assay in der Diagnose sowie der Rezidiv- bzw. Verlaufsbeurteilung beim Multiplen Myelom
Neuropathie bei monoklonalen Gammopathien - Kategorisierung und Definition von Kriterien für Therapiebedarf
Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance | Bone Marrow Transplantation
Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma - Donk - 2016 - International Journal of Laboratory Hematology - Wiley Online Library
Multiples Myelom – Plasmozytom
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia
Bestimmung freier Leichtketten im Serum bei Plasmazelldyskrasien - 10 - 2009 - Heftarchiv - AMT
Diagnosis of monoclonal gammopathy of renal significance - ScienceDirect
Multiples Myelom — Onkopedia
Monoklonale Gammopathie – Wikipedia
IJMS | Free Full-Text | Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
MCRT Webcast: MGUS and Smoldering Myeloma (SMM) - HealthTree for Multiple Myeloma
Multiples Myelom - E-Learning mit Lecturio
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia
Wann sollte bei monoklonaler Gammopathie eine Nierenbiopsie erfolgen? | SpringerLink